BMC Neurology

official impact factor 2.80

This article is part of the supplement: Proceedings of the 2009 Drug Discovery for Neurodegeneration Conference

Open Access Proceedings

ADDME – Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective

Katya Tsaioun*, Michel Bottlaender, Aloise Mabondzo and the Alzheimer's Drug Discovery Foundation

BMC Neurology 2009, 9(Suppl 1):S1 doi:10.1186/1471-2377-9-S1-S1

No comments have yet been made on this article.

Post a comment